Floxuridine

CHEMBL917 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
246.2 g/mol
LogP
-1.2
Phase
4

This chemotherapy drug is converted in the body to compounds that disrupt DNA and RNA synthesis in rapidly dividing cancer cells. It is infused directly into the artery supplying the liver to treat cancer that has spread from the colon to the liver.

Moleküler Ağırlık

246,1900 g/mol

LogP

-1,20

TPSA

99,10 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F

InChI

InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1

Molecular Formula

C9H11FN2O5

HBD / HBA

3 / 6

Döndürülebilir Bağlar

2

Ağır Atomlar

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This chemotherapy drug is converted in the body to compounds that disrupt DNA and RNA synthesis in rapidly dividing cancer cells. It is infused directly into the artery supplying the liver to treat cancer that has spread from the colon to the liver.

Yes, Floxuridine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL917. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5790. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.